Agenus has reported deep tumour responses and no observed colorectal [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

The first UK patient has been dosed with a personalised [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

NICE has recommended cemiplimab for eligible adults with recurrent or [...]

The UK health watchdog NICE has recommended NHS reimbursement of [...]

Context Therapeutics has reported encouraging interim Phase 1 data for [...]

Poolbeg Pharma has activated the first clinical site and begun [...]